Budget vs premium
altRx vs Gala: Which Costs Less Over 12 Months? (2026)
Compare altRx and Gala on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 8.7 and 7.7 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two platforms, one drug class, and a difference in annual cost most people do not notice until month four. That is the altRx versus Gala question.
Gala costs 2.8x more per month than altRx once promotional pricing is out of the picture ($249/mo against $89/mo). Over a year that gap compounds into real money, and the question is what it buys.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest 12-month cost
- altRx — $1,068 against $2,148 at Gala, on each provider's own best published pricing.
- Most predictable bill
- altRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Most support included
- altRx — Responsive care team for ongoing clinician-guided support.
The short version: altRx vs Gala
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| altRx | Gala | |
|---|---|---|
| Advertised price | Semaglutide $89/mo, tirzepatide $149/mo | From $249/mo, as low as $179/mo on longer plans |
| Rate after promotions | $89/mo | $249/mo |
| Pricing structure | Flat rate at every dose | Cheaper per month the longer you commit |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Shipping | Free, discreet 2-day delivery | Home delivery |
| Support model | Clinician messaging included | Provider check-ins included |
| Tirzepatide | $149/mo | Not published |
| Price transparency | Published upfront | Published upfront |
| Patient reviews | 14,820 | 2,870 |
| eRxDoctor score | 8.7/10 | 7.7/10 |
The real cost: six months and twelve
The advertised rate answers the wrong question. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| altRx | Gala | |
|---|---|---|
| First month | $89 | $249 |
| Months 2 onward | $89/mo | $249/mo |
| 6-month total | $534 | $1,494 |
| 12-month total | $1,068 | $2,988 |
| Best published plan | No multi-month discount published | longer-term plan at $179/mo — $2,148/yr |
altRx finishes the year $1,080 cheaper. For some patients the support Gala bundles closes that gap; for a patient who only needs the prescription written, it does not.
What the price difference actually buys
Before treating the cheaper option as the obvious one, it is worth naming what the more expensive one includes — at Gala that is provider check-ins and dose monitoring included, plus home delivery.
altRx's answer is the cheapest published tirzepatide rate on this list at $149, with the injection kit included. What it does not carry: the rate is a limited offer and the platform does not operate in every state.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
altRx in detail
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery.
Intake is 100% online medical visits. Fulfillment is free, discreet 2-day delivery. The commercial terms are flat rate at every dose, published upfront.
Behind the prescription sits responsive care team for ongoing clinician-guided support. Available medication: compounded semaglutide and compounded tirzepatide.
altRx pros
- Free and discreet 2-day delivery
- No commitment, cancel anytime
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
- Responsive care team for ongoing clinician-guided support
altRx cons
- Compounded medication, not FDA-approved branded product
- Not available in all U.S. states
The cost of choosing this over Gala: the rate is a limited offer and the platform does not operate in every state.
How Gala works
Gala positions itself on a direct-pay model with dose monitoring included rather than sold as an add-on. Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
Practically: fully online, no in-office visits, home delivery, and a pricing model that is cheaper per month the longer you commit.
On the clinical side, provider check-ins and dose monitoring included, prescribing compounded semaglutide and compounded tirzepatide.
Gala pros
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
- Fully online, no in-office visits required
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
Against altRx specifically, the trade you are making: the entry price sits above most compounded competitors unless you commit to a longer term.
altRx or Gala: matching the program to the patient
Choose altRx if:
- you would rather use the platform with the longer public record (14,820 reviews)
- the twelve-month total is what you are optimizing ($1,068 against $2,988)
- you would get real value from the cheapest published tirzepatide rate on this list at $149, with the injection kit included
- the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
Choose Gala if:
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you want to start on their timeline: fully online, no in-office visits
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
- the feature you would actually use: a direct-pay model with dose monitoring included rather than sold as an add-on
The trade-offs, stated plainly
On price. The monthly gap is 2.8x in altRx's favor. Whether that is a saving or a false economy turns on one thing: the rate is a limited offer and the platform does not operate in every state.
On predictability. Flat rate at every dose versus cheaper per month the longer you commit. Whichever you pick, get the maintenance-dose price in writing at intake.
On access. altRx advertises 100% online medical visits and free, discreet 2-day delivery; Gala advertises fully online, no in-office visits and home delivery. Coverage differs too — not available in every state against not published — which decides the question before price does if you are in a restricted state.
On medication. altRx covers compounded semaglutide and compounded tirzepatide; Gala covers compounded semaglutide and compounded tirzepatide. Only altRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
What the evidence actually says
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
altRx vs Gala: common questions
Which is cheaper to start, altRx or Gala?
altRx, at $89 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, altRx or Gala?
altRx, at roughly $1,068 for twelve months against $2,148 at Gala, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
How fast can I start with altRx compared with Gala?
altRx advertises 100% online medical visits, with free, discreet 2-day delivery. Gala advertises fully online, no in-office visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Is altRx or Gala better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis altRx has the stronger case; after month three, cost should take over.
Can I switch from altRx to Gala later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date, and check the refund terms on any prepaid plan first.
Are altRx and Gala legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. altRx operates on flat rate at every dose with pricing published upfront, Gala on cheaper per month the longer you commit, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Neither altRx nor Gala penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
The verdict
On the numbers, altRx wins the year: $1,068 against $2,148. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
The case for Gala is a direct-pay model with dose monitoring included rather than sold as an add-on. That is worth $90 a month to some patients and nothing at all to others — be honest about which you are.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- altRx vs He & She MDBudget vs premium
- altRx vs MaximusTirzepatide access
- Gala vs He & She MDCoaching-supported vs medication-only
- Gala vs MaximusBudget vs premium
- JoinFridays vs MeasuredBudget vs premium
- JoinFridays vs RefillsBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or Gala, and does not sell treatment. Read our ranking methodology.